Market revenue in 2023 | USD 73.0 million |
Market revenue in 2030 | USD 123.2 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.44% in 2023. Horizon Databook has segmented the North America cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Cannula market in North America can be attributed to advancements in healthcare infrastructure, increase in the number of patients undergoing surgeries, rise in government support, growth in investments in R&D, and increase in the number of minimally invasive procedures being performed.
However, factors such as stringent regulatory framework in some countries may restrain the market growth. In addition, the demand for cosmetic surgery is increasing in North America. As per American Society of Plastic Surgeons (ASPS) in 2018, there was continued growth in cosmetic procedures over the last year.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account